SCIENTURE HOLDINGS, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
SCIENTURE HOLDINGS, INC. (SCNX) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $8.09 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-06-30 was -$0.15, a 140.54% decline year-over-year.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-03-31 was $26.89, a 3854.41% increase year-over-year.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-09-30 was -$4.46.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-06-30 was $0.37.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was $8.09.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was -$12.25.
- SCIENTURE HOLDINGS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was -$2.67.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $8.09 10-K · filed 2026-03-30 | |||||||
| 2024-09-30 | $17.17 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$0.15 10-Q · filed 2025-08-12 | $22.60 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | $26.89 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$12.25 10-K · filed 2025-03-26 | -$5.40 10-K · filed 2024-04-22 | ||||||
| 2023-09-30 | -$4.46 10-Q · filed 2024-11-06 | -$4.35 10-Q · filed 2024-01-16 | -$3.88 10-Q · filed 2024-11-06 | -$5.82 10-Q · filed 2024-01-16 | ||||
| 2023-06-30 | $0.37 10-Q · filed 2024-08-09 | $1.02 10-Q · filed 2024-08-09 | -$0.52 10-Q · filed 2023-08-18 | |||||
| 2023-03-31 | $0.68 10-Q · filed 2024-06-26 | -$0.04 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$2.67 10-K · filed 2024-04-22 | |||||||
| 2022-09-30 | -$0.34 10-Q · filed 2024-01-16 | -$1.14 10-Q · filed 2024-01-16 | ||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||||
| 2016-03-31 | -$0.01 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |